公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2018 | Carbapenem Nonsusceptible Klebsiella pneumoniae in Taiwan: Dissemination and Increasing Resistance of Carbapenemase Producers During 2012-2015 | Chiu S.-K.; Ma L.; Chan M.-C.; Lin Y.-T.; Fung C.-P.; Wu T.-L.; Chuang Y.-C.; Lu P.-L.; JANN-TAY WANG ; Lin J.-C.; Yeh K.-M. | Scientific Reports | 41 | 35 | |
2015 | Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: A nationwide multicenter study in Taiwan | Chang Y.-Y.; Chuang Y.-C.; Siu L.K.; Wu T.-L.; Lin J.-C.; Lu P.-L.; JANN-TAY WANG ; Wang L.-S.; Lin Y.-T.; Huang L.-J.; Fung C.-P. | Journal of Microbiology, Immunology and Infection | 50 | 42 | |
1999 | Clones of lactobacillus casei and Torulopsis glabrata associated with recurrent abdominal wall abscess | Lu P.-L.; PO-REN HSUEH ; YEE-CHUN CHEN ; LEE-JENE TENG ; SHAN-CHWEN CHANG ; KWEN-TAY LUH | Journal of the Formosan Medical Association | 8 | 7 | |
2014 | Comparison of serological response to doxycycline versus benzathine penicillin G in the treatment of early syphilis in HIV-infected patients: A multi-center observational study | Tsai J.-C.; Lin Y.-H.; Lu P.-L.; Shen N.-J.; Yang C.-J.; Lee N.-Y.; Tang H.-J.; Liu Y.-M.; Huang W.-C.; Lee C.-H.; Ko W.-C.; Chen Y.-H.; Lin H.-H.; Chen T.-C.; CHIEN-CHING HUNG | PLoS ONE | 34 | 25 | |
2010 | Compassionate use of linezolid for adult taiwanese patients with bone and joint infections | Lu P.-L.; JANN-TAY WANG ; Chen C.-J.; Chen W.-C.; Chen T.-C.; Hwang Y.-C.; SHAN-CHWEN CHANG | Chemotherapy | 11 | 8 | |
2007 | Completely parylene-coated neuroprobe for chronic recording | Lu P.-L.; Fan C.-L.; Yang L.-J.; Lin C.-W. ; Yang Y.-J.; YAO-JOE YANG ; FU-SHAN JAW | 2nd IEEE International Conference on Nano/Micro Engineered and Molecular Systems, IEEE NEMS 2007 | 3 | 0 | |
2012 | Correlation between carbapenem consumption and resistance to carbapenems among Enterobacteriaceae isolates collected from patients with intra-abdominal infections at five medical centers in Taiwan, 2006-2010 | Ho C.-M.; Ho M.-W.; Liu Y.-C.; Toh H.-S.; Lee Y.-L.; Liu Y.-M.; Huang C.-C.; Lu P.-L.; Liu C.-E.; Chen Y.-H.; Ko W.-C.; Tang H.-J.; Yu K.-W.; Chen Y.-S.; Chuang Y.-C.; Wang J.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 19 | 18 | |
2009 | Corrigendum to "Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci" [Int. J. Antimicrob. Agents 32 (2008) S184-S187] (PII:S0924-8579(08)X0017-2) | Tsao S.-M.; Lin H.-C.; Lee C.-M.; Hsu G.-J.; Chen C.-M.; Sun W.; Liu Y.-C.; Jang T.-N.; Cheng Y.-J.; Lu P.-L.; Chiang P.-C.; Wang L.-S.; HSIANG-CHI KUNG ; Chuang Y.-C.; Shi Z.-Y.; Liu J.-W.; Huang C.-H.; Lu C.-T.; Liao C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 17 | 0 | |
2013 | Dissemination of imipenem-resistant Acinetobacter baumannii with new plasmid-borne blaOXA-72 in Taiwan | Kuo S.-C.; Yang S.-P.; Lee Y.-T.; Chuang H.-C.; Chen C.-P.; Chang C.-L.; Chen T.-L.; Lu P.-L.; PO-REN HSUEH ; Fung C.-P. | BMC Infectious Diseases | 25 | 25 | |
2017 | Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008-14: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) | Jean S.-S.; PO-REN HSUEH ; Korman T.; Ellem J.; George N.; Coombs G.; Ling T.; Tsang O.; Balaji V.; Mikamo H.; Kusachi S.; Mizutani T.; Kim M.-J.; Bae I.-G.; Umur N.B.; Rajasekaram D.G.; Taylor S.; Roberts S.; van der Werff K.; Drinkovic D.; Lagamayo E.; Mendoza M.; Tan T.Y.; Krishnan P.; Wang E.; Lu P.-L.; Liu C.-E.; Chuang K.Y.-C.; Yu K.-W.; Chen Y.-S.; Lu M.-C.; Panthuwong S.; Kiratisin P.; Phoung N.T.M.; Phuong D.M.; Van N.T.; Nga T.T.T.; SMART Asia-Pacific Group | Journal of Antimicrobial Chemotherapy | 81 | 77 | |
2020 | Does antimicrobial therapy affect mortality of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria? A nationwide multicenter study in Taiwan | Chuang C.; Su C.-F.; Lin J.-C.; Lu P.-L.; Huang C.-T.; JANN-TAY WANG ; Chuang Y.-C.; Kristopher Siu L.; Fung C.-P.; Lin Y.-T. | Microorganisms | 4 | 4 | |
2019 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials | Cahn P.; Madero J.S.; Arribas J.R.; Antinori A.; Ortiz R.; Clarke A.E.; CHIEN-CHING HUNG ; Rockstroh J.K.; Girard P.-M.; Sievers J.; Man C.; Currie A.; Underwood M.; Tenorio A.R.; Pappa K.; Wynne B.; Fettiplace A.; Gartland M.; Aboud M.; Smith K.; Cassetti L.; David D.; Figueras L.; Losso M.; Lopardo G.; Lupo S.; Porteiro N.; Sánchez M.; Bloch M.; Cooper D.; Finlayson R.; Kelleher A.; Koh K.; Lewis D.; McMahon J.; Moore R.; Roth N.; Shields M.; De Wit S.; Florence E.; Goffard J.-C.; Demeester R.; Lacor P.; Vandercam B.; Vandekerckhove L.; Angel J.; Baril J.-G.; Conway B.; De Pokomandy A.; Szabo J.; Walmsley S.; Bouchaud O.; Chidiac C.; Delobel P.; Goujard C.; Katlama C.; Molina J.-M.; Pialoux G.; Philibert P.; Bogner J.; Esser S.; Krznaric I.; Lehmann C.; Spinner C.; Stellbrink H.-J.; Stephan C.; Stoehr A.; Barchi E.; Caramello P.; Castelli F.; Cattelan A.M.; D'Arminio Monforte A.; Di Biagio A.; Di Perri G.; Gori A.; Maggiolo F.; Menzaghi B.; Migliorino G.; Mussini C.; Penco G.; Puoti M.; Rizzardini G.; Gulminetti R.; Lazzarin A.; Quirino T.; Sighinolfi L.; Viale P.; Amaya Tapia G.; Andrade Villanueva J.; Granados Reyes E.R.; Perez Rios A.; Santoscoy Gomez M.; Den Hollander J.; Rijnders B.; Hidalgo J.A.; Hercilla Vasquez L.; Illescas L.; Olczak A.; Mansinho K.; Correia Pacheco P.P.; Teófilo E.; Saraiva da Cunha J.; Sarmento e Castro R.; Serrão R.; Arbune M.; Jianu C.; Oprea A.; Preotescu L.; Prisacariu L.-J.; Belonosova E.; Borodkina O.; Chernova O.; Gankina N.; Kizhlo S.; Kulagin V.; Kurina N.; Nagimova F.; Pokrovsky V.; Ryamova E.; Voronin E.; Yakovlev A.; Kaplan R.; Lee S.H.; Kim S.-W.; Kim S.-I.; Kim W.J.; Antela Lopez A.; Casado Osorio J.L.; Castaño Carracedo M.A.; De Los Santos Gil I.; Estrada Perez V.; Falco Ferrer V.; Force L.; Galinda Puerto M.J.; Garcia Deltoro M.; Gatell J.M.; Goenaga Sanchez M.A.; González Cordón A.; Knobel H.; Lopez Bernaldo de Quiros J.C.; Losa Garcia J.E.; Masia M.; Montero-Alsonso M.; Ocampo Hermida A.; Pasquau Liaño J.; Portilla Sogorb J.; Pulido Ortega F.; Rivera Roman A.; Santos Fernandez J.R.; Torres Perea R.; Troya Garcia J.; Viciana Fernandez P.; Calmy A.; Hauser C.; Fehr J.; Cheng S.-H.; Ko W.-C.; Lin H.-H.; Lu P.-L.; Tseng Y.-T.; Wang N.-C.; Wong W.-W.; Yang C.-J.; Arduino R.; Benson P.; Berhe M.; Bredeek F.; Brinson C.; Campbell T.; Crofoot G.; Cunningham D.; DeJesus E.; Dretler R.; Eron J.; Fife K.; Fichtenbaum C.; Flamm J.; Goldstein D.; Gupta S.; Hagins D.; Hoffman-Terry M.; Jayaweera D.; Kinder C.; Klein D.; McDonald C.; Mills A.; Nahass R.; Osiyemi O.; Overton E.; Parks D.; Prelutsky D.; Ramgopal M.; Schrader S.; Sha B.; Simon G.; Sims J.; Skiest D.; Slim J.; Tashima K.; Thedinger B.; Gazzard B.; Fox J.; Johnson M.; Kegg S.; Khoo S.; Mazhude C.; Orkin C.; Schembri G.; Ustianowski A.; GEMINI Study Team | The Lancet | 252 | 238 | |
2021 | Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV | Lee Y.-L.; KUAN-YIN LIN ; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | International Journal of Antimicrobial Agents | 2 | 0 | |
2019 | Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors | Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN ; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; CHIEN-CHING HUNG ; on behalf of the Taiwan HIV Study Group | Hepatology | 17 | 15 | |
2021 | Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients | YU-SHAN HUANG ; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; HSIN-YUN SUN ; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | Journal of acquired immune deficiency syndromes (1999) | 10 | 9 | |
2015 | Emergence of OXA-48-producing Klebsiella pneumoniae in Taiwan | Ma L.; JANN-TAY WANG ; Wu T.-L.; Siu L.K.; Chuang Y.-C.; Lin J.-C.; Lu M.-C.; Lu P.-L. | PLoS ONE | 49 | 43 | |
2012 | Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) | Lu P.-L.; Liu Y.-C.; Toh H.-S.; Lee Y.-L.; Liu Y.-M.; Ho C.-M.; Huang C.-C.; Liu C.-E.; Ko W.-C.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Chen Y.-S.; Chuang Y.-C.; Xu Y.; Ni Y.; Chen Y.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 151 | 135 | |
2017 | Epidemiology and Predictors of NTM Pulmonary Infection in Taiwan - A Retrospective, Five-Year Multicenter Study | Huang H.-L.; Cheng M.-H.; Lu P.-L.; CHIN-CHUNG SHU ; JANN-YUAN WANG ; JANN-TAY WANG ; Chong I.-W.; LI-NA LEE | Scientific Reports | 59 | 52 | |
2021 | The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients | Kuo S.-H.; Lu P.-L.; YEE-CHUN CHEN ; Ho M.-W.; Lee C.-H.; Chou C.-H.; Lin S.-Y. | Journal of the Formosan Medical Association | 11 | 9 | |
2014 | First report of blaIMP-8 in raoultella planticola | Tseng S.-P.; JANN-TAY WANG ; Liang C.-Y.; Lee P.-S.; YEE-CHUN CHEN ; Lu P.-L. | Antimicrobial Agents and Chemotherapy | 43 | 41 | |